STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
22 hedge funds and large institutions have $5.61M invested in Statera Biopharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.51M | |
| 2 | +$1.11M | |
| 3 | +$194K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$189K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$141K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$184K | |
| 3 | -$59K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$52K |
| 5 |
Barclays
London,
United Kingdom
|
-$26K |